Position in ABT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$20,687,358
-$2,888,446 QoQ
Shares Held
227,985
-0.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
10.45%
of 13F equity value
Holder Rank
#336
of 2,948 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Derivatives in ABT
reported options exposure · as of Jun 30, 2025CallValue
$31,715,491
CallShares
233,185
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026CURA WEALTH ADVISORS, LLC holds $20,732,858 across 2 Medical Devices names. ABT ranks #1 (99.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
227,985 | $20,687,358 | |
| 2 | TLSI |
TriSalus Life Sciences, Inc.
|
10,000 | $45,500 |
All Filings in ABT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,687,358 | 227,985 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $23,575,804 | 229,627 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $28,550,208 | 227,873 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $30,437,998 | 227,251 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $31,715,491 | 233,185 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $31,259,503 | 235,654 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,490,362 | 234,200 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||